12:01:02 EST Thu 27 Nov 2025
Enter Symbol
or Name
USA
CA



Plantify Foods Inc (2)
Symbol PTFY
Shares Issued 11,440,489
Recent Sedar Documents

ORIGINAL: Plantify Foods Reports Resumption to Trading

2025-11-26 19:55 ET - News Release

(via TheNewswire)

Plantify Foods, Inc.
   

Vancouver, British Columbia – TheNewswire – November 26, 2025 -  Plantify Foods, Inc .  (TSXV: PTFY)  (" Plantify " or the " Company ") is pleased to report that the TSX Venture Exchange (“ TSXV ”) has advised of the intended resumption to trading of the Company’s common shares.

As at October 31, 2025, the Company had a working capital deficiency of approximately $850,000. The Company plans to undertake one or more financings to address this deficiency, but no assurance can be given that any such financing will be available or, if available, that it will be on terms that are acceptable to the Company.

The Company does not currently meet the asset and operations criteria of TSXV (the “ CLR Requirements ”) as the Company does not currently have a business. The Company’s management intends to evaluate potential business opportunities that will enable the Company to satisfy the CLR Requirements, but no assurance can be given that the Company will be able to identify or secure any such business opportunity. If the Company does not secure a business opportunity within approximately 90 days, it may be transferred to the NEX.

The Company also reports that, further to its news release of August 22, 2025, it wasn’t able to obtain TSXV acceptance to the extension of the conversion feature of debentures in the aggregate principal sum of $240,000 because trading in the Company’s shares was then halted. Accordingly, such debentures are no longer convertible into common shares of Plantify.  

Contact:

Gabriel Kabazo

Chief Financial Officer & Corporate Secretary

Phone: 778 601 8420

  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Copyright (c) 2025 TheNewswire - All rights reserved.

© 2025 Canjex Publishing Ltd. All rights reserved.